Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
09/2008
09/18/2008US20080227770 Benzoxazepine Compound
09/18/2008US20080227748 Medicament Made From Laminarine or Oligolaminarines For Treatment of Septicemia and Septic Shock
09/18/2008US20080227691 Blood Coagulation FVIII Analogues
09/18/2008US20080227200 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and DNA coding for the same
09/18/2008US20080227152 In vivo incorporation of unnatural amino acids
09/18/2008US20080226750 for inducing apnea and treating shock; chalcogenides
09/18/2008US20080226612 Compositions of Cells Enriched for Combinations of Various Stem and Progenitor Cell Populations, Methods of Use Thereof and Methods of Private Banking Thereof
09/18/2008US20080226608 Methods of Isolating and Using Enriched Subpopulations of Bone Marrow Progenitors for the Treatment of Diabetes
09/18/2008US20080226583 Therapeutic polyesters and polyamides
09/18/2008US20080226579 Using water soluble ion exchange resin; stability; masking bitter taste
09/18/2008DE102007012645A1 Substituierte Imidazo- und Triazolopyrimidine Substituted imidazo and triazolopyrimidines
09/18/2008CA2680824A1 Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
09/18/2008CA2680759A1 Kunitz-type recombinant inhibitor
09/17/2008EP1970072A1 Use of GLP-2 peptides for the treatment of hyperparathyroidism
09/17/2008EP1969368A2 Potentiation of apoptosis by monoclonal antibodies
09/17/2008EP1969011A1 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (nait)
09/17/2008EP1968626A1 Thrombin-free biological adhesive and use thereof as a medicament
09/17/2008EP1200555B1 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell
09/17/2008EP1036095B1 Oxygen-transporting albumin-based blood replacement composition and blood volume expander
09/17/2008CN101267832A Platelet aggregation inhibitor and health food effective in inhibiting platelet aggregation
09/17/2008CN101267831A Compositions and methods for promoting hemostasis and other physiological activities
09/17/2008CN101267823A Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects
09/17/2008CN101265299A Biologically active peptides from functional domains of bactericidal permeability-increasing protein and uses thereof
09/17/2008CN101264320A Oxygen-carrying blood substitute preparations
09/17/2008CN101264316A Preparation of medicinal protolysate
09/17/2008CN101264300A Medicaments assembly for moistening lung and nourishing kidney, enriching blood and tonifying Qi and preparation thereof
09/17/2008CN101264253A Chinese medicinal composition for treating diabetes insipidus and preparation thereof
09/17/2008CN101264242A Medicaments preparations for treating hemorrhage, pain and dropsy
09/17/2008CN101264238A Preparation of Chinese medicine for treating iron deficiency anemia
09/17/2008CN101264229A Medicaments assembly for nourishing blood and nourishing heart, promoting blood and qi circulation and preparation thereof
09/17/2008CN101264220A Medicaments assembly for tonifying kidney and invigorating spleen, activating blood circulation and removing stasis and preparation thereof
09/17/2008CN101264182A Hemogenesis marrow-benefiting medicine
09/17/2008CN101264180A Application of downy grape and its extraction in preparing antithrombotic medicaments
09/17/2008CN101264161A Qi-benefitting nourishing blood-nourishing sedatives and preparation thereof
09/17/2008CN101264150A Chinese medicinal composition containing radix astragali and preparation thereof
09/17/2008CN101264127A Sophora alopecuroids total alkaloid powder injection and preparation thereof
09/17/2008CN101264118A Preparation of cirsium japonicum root powder preparation and uses thereof
09/17/2008CN101264112A Ligusticum dhuanxiong oil micro-emulsion and preparation thereof
09/17/2008CN101264077A Lignans and its use for preparing antiphlogistic antiendotoxin medicaments
09/17/2008CN101264073A Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
09/17/2008CN101264072A Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
09/17/2008CN101264051A Modified release pharmaceutical formulation
09/17/2008CN101263857A Blood sugar reducing tea and making method thereof
09/17/2008CN100418977C Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
09/17/2008CN100418968C Pirazino(aza)indole derivatives
09/17/2008CN100418955C Novel Benzo-fused heterocycles
09/17/2008CN100418535C Aescin medicine composition and its prepn process and use
09/17/2008CN100418526C Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension
09/17/2008CN100418518C Injectable diacetylamino acetic ethylenediamine prepn. preparing method and quality-control tech. therefor
09/17/2008CN100418430C Biological health tea
09/16/2008US7425641 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
09/16/2008US7425639 Process
09/16/2008US7425610 Expression vector comprising nucleotide sequences coding novel receptor protein for use in prevention and treatment of cell proliferative and autoimmune disorders
09/16/2008US7425568 Compounds, which are potent inhibitors of Na+ /Ca2+ exchange mechanism and are useful in the treatment of arrhythmias
09/16/2008US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
09/16/2008US7425331 Protein A methods of use
09/16/2008US7425326 Degrading collagen within an atherosclerotic plaque in a chronically occluded animal tube or cavity by administering proteolytic enzyme; angioplasty
09/16/2008US7425325 binding ligands and proteins comprising amino acid sequences, having high specificity for the receptor zcytor17, used to induce proinflammatory cytokine production, for stimulating the immune system and proliferation and/or development of hematopoietic cells in vitro and in vivo; antibodies
09/16/2008CA2480429C Novel therapeutical use of agonist ligands specific to g2a receptor
09/16/2008CA2202470C Intracellular isoform of the interleukin-1-receptor antagonist
09/12/2008WO2008109840A1 Tricyclic compounds useful in treating iron disorders
09/12/2008WO2008108742A2 Polymorphic forms of clopidogrel hydrobromide
09/12/2008WO2008108309A1 Fused pyridine derivative
09/12/2008WO2008108291A1 Process for production of prasugrel hydrochloride having high purity
09/12/2008WO2008107363A1 New blood coagulation factor inhibitors
09/12/2008WO2008107362A2 Stabiliser and inhibitors of factor vii
09/12/2008WO2008107211A2 Novel p2y12 receptor antagonists
09/12/2008WO2008081116A3 Cellular preparations for use as a revascularisation stimulating agent
09/12/2008WO2008074851A3 Method for inhibiting the expression of endogenous erythropoietin (epo)
09/12/2008WO2008030947A3 Use of unactivated calcium exchanged zeolites in hemostatic devices and products
09/12/2008CA2678895A1 Tricyclic compounds useful in treating iron disorders
09/11/2008US20080221204 Materials and Methods for Treating Coagulation Disorders
09/11/2008US20080221120 Identify pyrazole imine derivatives that modulate activity of aquaporin-; culturing a cell expressing an aquaporin-1 (AQP1) in the presence of an agent, determine effect on cell migration, cell adhesion, cell proliferation; treat cellular proliferative disease, cancer
09/11/2008US20080221082 of the alpha V beta 3 integrin receptor; , thromboembolic events, cardiovascular disorders, lung diseases, disorders of the CNS, the kidney, the gastrointestinal tract or inflammation
09/11/2008US20080221034 Canine specific growth hormone releasing hormone
09/11/2008US20080221032 Proteinaceous construct; an activated factor VII molecule anda 1-4 polysialic acid; controlling bleeding in a mammal during surgery or trauma
09/11/2008US20080221031 Kit; an anti-fibrinolytic agent, reducing or preventing perioperative blood loss associated with various ischemias in patients subjected to invasive surgical procedures
09/11/2008US20080221022 Administering prouroguanylin and a diuretic; kidney disease, heart disease, liver disease, hypertension
09/11/2008US20080220095 Red blood cells loaded with s-nitrosothiol and uses therefor
09/11/2008US20080220017 administering modified virus particles having reduced lipid content, drugs carriers and immunostimulants, to provide protection against infection by viral diseases
09/11/2008US20080220016 Method of Treating and Preventing Infectious Diseases via Creation of a Modified Viral Particle with Immunogenic Properties
09/11/2008US20080219998 Anticoagulant for use in treatment and prevention of thrombosis or thrombin-dependent vaso-occlusive disease; selective reduction of intravascular thromboplastin antecedent activity
09/11/2008US20080219983 Antihemophilic factor specific peptides for use as therapeutic tools in treatment of blood disorders
09/11/2008US20080219967 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases
09/10/2008EP1967523A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application
09/10/2008EP1967522A1 New blood coagulation factor inhibitors
09/10/2008EP1967513A1 Novel P2Y12 receptor antagonists
09/10/2008EP1967195A1 Antacid
09/10/2008EP1966219A1 Process for the preparation of s-(+)-clopidogrel by optical resolution
09/10/2008EP1966215A1 Condensed heterocyclic compounds useful as dpp-iv inhibitors
09/10/2008EP1966203A2 Oxazoloisoquinoline derivatives as thrombin receptor antagonists
09/10/2008EP1966141A1 Six-membered heterocycles useful as serine protease inhibitors
09/10/2008EP1965778A2 Novel uses for drugs targeting glutamine synthetase
09/10/2008EP1605954B1 A food-supplement composition suitable for promoting iron absorption
09/10/2008EP1451222B1 Proteins with il-6 inhibiting activity
09/10/2008EP1441771B1 Aqueous sustained-release formulations of proteins
09/10/2008EP1392375B1 Composition and use of substances for stabilising amino acids containing sulphur
09/10/2008EP1368302B1 Novel amino dicarboxylic acid derivatives
09/10/2008EP1350511B1 Medicinal compositions containing aspirin
09/10/2008EP1301474B1 Tyrosine derivatives as phosphatase inhibitors